However, risk stratification according to genetic profiles such as MGMT promoter methylation or IDH gene mutation of the tumor demonstrated a subgroup of patients, although a minority, shows an unexpected long-term survival for GBM [2, 26]. This evidence concerns the gene MGMT and neoplasm.